113 related articles for article (PubMed ID: 6259569)
1. Antiferritin IgG antibody for isotopic cancer therapy.
Order SE; Klein JL; Leichner PK
Oncology; 1981; 38(3):154-60. PubMed ID: 6259569
[TBL] [Abstract][Full Text] [Related]
2. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
Order SE; Stillwagon GB; Klein JL; Leichner PK; Siegelman SS; Fishman EK; Ettinger DS; Haulk T; Kopher K; Finney K
J Clin Oncol; 1985 Dec; 3(12):1573-82. PubMed ID: 2415692
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry of 131I-labeled antiferritin in hepatoma: specific activities in the tumor and liver.
Leichner PK; Klein JL; Siegelman SS; Ettinger DS; Order SE
Cancer Treat Rep; 1983; 67(7-8):647-58. PubMed ID: 6307515
[TBL] [Abstract][Full Text] [Related]
4. Use of isotopic immunoglobulin in therapy.
Order SE; Klein JL; Ettinger D; Alderson P; Siegelman S; Leichner P
Cancer Res; 1980 Aug; 40(8 Pt 2):3001-7. PubMed ID: 6249495
[TBL] [Abstract][Full Text] [Related]
5. Variables affecting the tumor localization of 131I-antiferritin in experimental hepatoma.
Rostock RA; Klein JL; Kopher KA; Order SE
Am J Clin Oncol; 1984 Feb; 7(1):9-18. PubMed ID: 6695855
[TBL] [Abstract][Full Text] [Related]
6. Distribution of and physiologic factors that affect 131I-antiferritin tumor localization in experimental hepatoma.
Rostock RA; Klein JL; Leichner PK; Order SE
Int J Radiat Oncol Biol Phys; 1984 Jul; 10(7):1135-41. PubMed ID: 6746354
[TBL] [Abstract][Full Text] [Related]
7. Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatoma.
Klein JL; Nguyen TH; Laroque P; Kopher KA; Williams JR; Wessels BW; Dillehay LE; Frincke J; Order SE; Leichner PK
Cancer Res; 1989 Nov; 49(22):6383-9. PubMed ID: 2553255
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry and treatment planning for 90Y-labeled antiferritin in hepatoma.
Leichner PK; Yang NC; Frenkel TL; Loudenslager DM; Hawkins WG; Klein JL; Order SE
Int J Radiat Oncol Biol Phys; 1988 May; 14(5):1033-42. PubMed ID: 2834309
[TBL] [Abstract][Full Text] [Related]
9. [131I antiferritin in the treatment of hepatoma and Hodgkin's disease].
Cohen Y; Moroz H
Harefuah; 1986 Dec; 111(11):398-9. PubMed ID: 3028919
[No Abstract] [Full Text] [Related]
10. Antiferritin immunoglobulin therapy for treatment of hepatoma.
Held J; McLaughlin P
Oncol Nurs Forum; 1987; 14(5):27-31. PubMed ID: 2821514
[No Abstract] [Full Text] [Related]
11. Selective tumor localization in experimental hepatoma by radiolabeled antiferritin antibody.
Rostock RA; Klein JL; Leichner P; Kopher KA; Order SE
Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1345-50. PubMed ID: 6885547
[TBL] [Abstract][Full Text] [Related]
12. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
Hellman S
J Clin Oncol; 1985 Dec; 3(12):1569. PubMed ID: 2999345
[No Abstract] [Full Text] [Related]
13. 90Yttrium antiferritin--a new therapeutic radiolabeled antibody.
Order SE; Klein JL; Leichner PK; Frincke J; Lollo C; Carlo DJ
Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):277-81. PubMed ID: 3005201
[TBL] [Abstract][Full Text] [Related]
14. A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: an RTOG study.
Order S; Pajak T; Leibel S; Asbell S; Leichner P; Ettinger D; Stillwagon G; Herpst J; Haulk T; Kopher K
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):953-63. PubMed ID: 1850722
[TBL] [Abstract][Full Text] [Related]
15. [Effect of radio-immunochemotherapy-using antiferritin antibody combined with anthracycline drugs on hepatocellular carcinoma cell].
Une Y; Sato Y; Alam S; Nagabuchi E; Hata Y; Uchino J
Gan To Kagaku Ryoho; 1993 Jan; 20(1):161-3. PubMed ID: 8380685
[No Abstract] [Full Text] [Related]
16. Dosimetry of 131I-labeled anti-ferritin in hepatoma: a model for radioimmunoglobulin dosimetry.
Leichner PK; Klein JL; Garrison JB; Jenkins RE; Nickoloff EL; Ettinger DS; Order SE
Int J Radiat Oncol Biol Phys; 1981 Mar; 7(3):323-33. PubMed ID: 6268576
[No Abstract] [Full Text] [Related]
17. The theoretical implications and experimental and clinical results of radiolabeled antiferritin.
Order SE
Acta Oncol; 1990; 29(6):689-94. PubMed ID: 2223137
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of radiolabeled polyclonal antiferritin in patients with Hodgkin's disease.
Lai J; Quadri SM; Borchardt PE; Harris L; Wucher R; Askew E; Schweichel L; Vriesendorp HM
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3315s-3323s. PubMed ID: 10541380
[TBL] [Abstract][Full Text] [Related]
19. Comparative tumor dose from 131I-labeled polyclonal anti-ferritin, anti-AFP, and anti-CEA in primary liver cancers.
Leichner PK; Klein JL; Fishman EK; Siegelman SS; Ettinger DS; Order SE
Cancer Drug Deliv; 1984; 1(4):321-8. PubMed ID: 6085756
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunodetection of tumors with monoclonal antiplacental ferritin antibody: preliminary results.
Moroz C; Lantsberg Z; Sela O; Cohen Y; Khodadadi J; Goldstein J; Quastel MR; Shoenfeld Y
Oncology; 1989; 46(1):35-9. PubMed ID: 2536915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
